About
Gain Therapeutics Inc (NASDAQ:GANX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 24 2026
Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026
Mar 26 2026
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update
Mar 19 2026
Gain Therapeutics to Present at the 38th Annual ROTH Conference
Mar 18 2026
Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
Mar 12 2026
Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update
Financials
Revenue
$0
Market Cap
$79.03 M
EPS
-0.61
Translate